Bbva Compass Bancshares Inc. Acquires 38 Shares of Maximus, Inc. (MMS)
Bbva Compass Bancshares Inc. raised its stake in shares of Maximus, Inc. (NYSE:MMS) by 0.9% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 4,084 shares of the health services provider’s stock after buying an additional 38 shares during the period. Bbva Compass Bancshares Inc.’s holdings in Maximus were worth $256,000 as of its most recent filing with the SEC.
Other hedge funds have also modified their holdings of the company. Great West Life Assurance Co. Can boosted its stake in shares of Maximus by 0.6% in the second quarter. Great West Life Assurance Co. Can now owns 38,710 shares of the health services provider’s stock valued at $2,423,000 after buying an additional 241 shares during the last quarter. Acadian Asset Management LLC acquired a new stake in shares of Maximus during the second quarter valued at approximately $2,228,000. Contravisory Investment Management Inc. acquired a new stake in shares of Maximus during the second quarter valued at approximately $5,597,000. First Midwest Bank Trust Division boosted its stake in shares of Maximus by 2.3% in the second quarter. First Midwest Bank Trust Division now owns 20,265 shares of the health services provider’s stock valued at $1,269,000 after buying an additional 465 shares during the last quarter. Finally, Legato Capital Management LLC acquired a new stake in shares of Maximus during the second quarter valued at approximately $269,000. Institutional investors own 97.89% of the company’s stock.
Maximus, Inc. (NYSE MMS) opened at 60.23 on Thursday. Maximus, Inc. has a one year low of $43.69 and a one year high of $64.97. The firm has a market cap of $3.90 billion, a price-to-earnings ratio of 19.75 and a beta of 1.39. The stock has a 50 day moving average of $61.34 and a 200 day moving average of $60.84.
Maximus (NYSE:MMS) last announced its earnings results on Thursday, August 3rd. The health services provider reported $0.79 earnings per share for the quarter, topping analysts’ consensus estimates of $0.76 by $0.03. Maximus had a net margin of 8.43% and a return on equity of 25.08%. The business had revenue of $600.40 million during the quarter, compared to the consensus estimate of $614.12 million. During the same quarter last year, the firm earned $0.79 earnings per share. Maximus’s quarterly revenue was down 2.7% on a year-over-year basis. Equities research analysts predict that Maximus, Inc. will post $3.12 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Thursday, August 31st. Investors of record on Tuesday, August 15th will be paid a dividend of $0.045 per share. This represents a $0.18 dividend on an annualized basis and a yield of 0.30%. The ex-dividend date of this dividend is Friday, August 11th. Maximus’s dividend payout ratio is presently 5.73%.
COPYRIGHT VIOLATION NOTICE: “Bbva Compass Bancshares Inc. Acquires 38 Shares of Maximus, Inc. (MMS)” was published by Watch List News and is the property of of Watch List News. If you are reading this story on another site, it was stolen and republished in violation of United States and international copyright and trademark legislation. The legal version of this story can be viewed at https://www.watchlistnews.com/bbva-compass-bancshares-inc-acquires-38-shares-of-maximus-inc-mms/1468150.html.
Several brokerages have commented on MMS. Zacks Investment Research cut shares of Maximus from a “buy” rating to a “hold” rating in a research report on Wednesday. Maxim Group set a $66.00 target price on shares of Maximus and gave the company a “hold” rating in a research report on Thursday, August 3rd. BidaskClub cut shares of Maximus from a “hold” rating to a “sell” rating in a research report on Monday, July 24th. Canaccord Genuity cut shares of Maximus from a “buy” rating to a “hold” rating and set a $62.00 target price for the company. in a research report on Tuesday, July 4th. Finally, KeyCorp reiterated a “sector weight” rating on shares of Maximus in a research report on Thursday, May 25th. One analyst has rated the stock with a sell rating and eight have issued a hold rating to the company. Maximus presently has a consensus rating of “Hold” and a consensus price target of $62.17.
In related news, President Bruce Caswell sold 8,000 shares of Maximus stock in a transaction on Thursday, May 18th. The shares were sold at an average price of $61.79, for a total transaction of $494,320.00. Following the completion of the transaction, the president now owns 35,904 shares of the company’s stock, valued at $2,218,508.16. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, General Counsel David Francis sold 1,000 shares of Maximus stock in a transaction on Friday, July 14th. The stock was sold at an average price of $60.46, for a total transaction of $60,460.00. Following the transaction, the general counsel now directly owns 15,715 shares of the company’s stock, valued at approximately $950,128.90. The disclosure for this sale can be found here. Insiders have sold 92,439 shares of company stock valued at $5,799,825 in the last three months. 3.10% of the stock is owned by insiders.
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS).
Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.